Obesity Drug Race Intensifies Between Novo Nordisk and Eli Lilly

The competition in the obesity drug market is heating up as pharmaceutical giants Novo Nordisk and Eli Lilly vie for market dominance, with Novo Nordisk making strides to catch up.

3 Aug, 05:02 — 3 Aug, 05:02

Post Share

Sources

Showing 1 of 1 sources

ReutersVery High15d ago

Obesity battle heats up again as Novo claws way back into race with Lilly - Reuters

Obesity battle heats up again as Novo claws way back into race with Lilly Reuters

Read full article →

PERSPECTA

PERSPECTA

Obesity Drug Race Intensifies Between Novo Nordisk and Eli Lilly

Sources

Obesity battle heats up again as Novo claws way back into race with Lilly - Reuters

Related Stories

German Farmers Report Significant Harvest Losses Due to Drought

Gold Price Expected to See Trend Reversal, Options Investors Bet on Shift

Mike Ashley's Frasers Group Increases Stake in Hugo Boss to 48%

Google to Shift All Pixel Production Out of China by 2027, Expanding to Vietnam and India

PERSPECTA